ZNF770 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.60910174074047E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.19219999983322E-07 |
Normal-vs-Stage2 |
3.922400E-03 |
Normal-vs-Stage3 |
1.63624669369256E-12 |
Normal-vs-Stage4 |
1.12350129199967E-11 |
Stage1-vs-Stage2 |
8.642600E-01 |
Stage1-vs-Stage3 |
6.799000E-04 |
Stage1-vs-Stage4 |
1.976960E-03 |
Stage2-vs-Stage3 |
1.142210E-01 |
Stage2-vs-Stage4 |
1.068420E-01 |
Stage3-vs-Stage4 |
8.958600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.60970142665451E-11 |
Normal-vs-AfricanAmerican |
1.90479999995219E-07 |
Normal-vs-Asian |
1.707980E-02 |
Caucasian-vs-AfricanAmerican |
3.321000E-01 |
Caucasian-vs-Asian |
8.955800E-01 |
AfricanAmerican-vs-Asian |
6.027600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.44164713289774E-12 |
Normal-vs-Female |
4.29269999546733E-08 |
Male-vs-Female |
1.725810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.53810000186527E-08 |
Normal-vs-Age(41-60Yrs) |
1.78830000030494E-07 |
Normal-vs-Age(61-80Yrs) |
1.59809943056644E-11 |
Normal-vs-Age(81-100Yrs) |
3.34639999999276E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.558400E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.554600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.568800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.337600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.590600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.057400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.411800E-01 |
Normal-vs-Grade 2 |
1.5624000000436E-06 |
Normal-vs-Grade 3 |
1.43679512731865E-11 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
6.695800E-02 |
Grade 1-vs-Grade 3 |
4.168100E-02 |
Grade 1-vs-Grade 4 |
7.896400E-03 |
Grade 2-vs-Grade 3 |
9.257400E-03 |
Grade 2-vs-Grade 4 |
1.29839999973846E-07 |
Grade 3-vs-Grade 4 |
1.423710E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.790300E-04 |
Normal-vs-ccB subtype |
3.07365244367475E-12 |
ccA subtype-vs-ccB subtype |
4.47850000000471E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.6008000197919E-09 |
Normal-vs-N1 |
2.341100E-03 |
N0-vs-N1 |
1.931210E-01 |
|
|